Epoch 11: Grants to Greenbacks - Biotech's Funding Journey

Catalyst Performance, China, NIH investment, Efficient Capital Allocation, Crossover Comeback, M&A timeline benchmarks

Welcome to the 74 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,704 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar!  Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update.  For…